Evidence map›Paper›PMID 26139464›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2015

Proangiogenic Properties of Thrombospondin-4.

Santoshi Muppala, Ella Frolova, Roy Xiao, Irene Krukovets, Suzy Yoon, George Hoppe, Amit Vasanji, Edward Plow, Olga Stenina-Adognravi

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 74 citations in OpenAlex.

  1. Maternal serum thrombospondin-4 levels in placenta accreta spectrum: A case-control study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Pathophysiological roles of thrombospondin-4 in disease development.Seminars in cell & developmental biology · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Santoshi MuppalaFrom the Department of Molecular Cardiology (S.M., E.F., R.X., I.K., E.P., O.S.-A.), and Cole Eye Institute (S.Y., G.H.), Cleveland Clinic, OH; and ImageIQ Inc, Cleveland, OH (A.V.).
Ella FrolovaFrom the Department of Molecular Cardiology (S.M., E.F., R.X., I.K., E.P., O.S.-A.), and Cole Eye Institute (S.Y., G.H.), Cleveland Clinic, OH; and ImageIQ Inc, Cleveland, OH (A.V.).
Roy XiaoFrom the Department of Molecular Cardiology (S.M., E.F., R.X., I.K., E.P., O.S.-A.), and Cole Eye Institute (S.Y., G.H.), Cleveland Clinic, OH; and ImageIQ Inc, Cleveland, OH (A.V.).
Irene KrukovetsFrom the Department of Molecular Cardiology (S.M., E.F., R.X., I.K., E.P., O.S.-A.), and Cole Eye Institute (S.Y., G.H.), Cleveland Clinic, OH; and ImageIQ Inc, Cleveland, OH (A.V.).
Suzy YoonFrom the Department of Molecular Cardiology (S.M., E.F., R.X., I.K., E.P., O.S.-A.), and Cole Eye Institute (S.Y., G.H.), Cleveland Clinic, OH; and ImageIQ Inc, Cleveland, OH (A.V.).
George HoppeFrom the Department of Molecular Cardiology (S.M., E.F., R.X., I.K., E.P., O.S.-A.), and Cole Eye Institute (S.Y., G.H.), Cleveland Clinic, OH; and ImageIQ Inc, Cleveland, OH (A.V.).
Amit VasanjiFrom the Department of Molecular Cardiology (S.M., E.F., R.X., I.K., E.P., O.S.-A.), and Cole Eye Institute (S.Y., G.H.), Cleveland Clinic, OH; and ImageIQ Inc, Cleveland, OH (A.V.).
Edward PlowFrom the Department of Molecular Cardiology (S.M., E.F., R.X., I.K., E.P., O.S.-A.), and Cole Eye Institute (S.Y., G.H.), Cleveland Clinic, OH; and ImageIQ Inc, Cleveland, OH (A.V.).
Olga Stenina-AdognraviFrom the Department of Molecular Cardiology (S.M., E.F., R.X., I.K., E.P., O.S.-A.), and Cole Eye Institute (S.Y., G.H.), Cleveland Clinic, OH; and ImageIQ Inc, Cleveland, OH (A.V.). stenino@ccf.org.
Group Image (Poland) · PL

Funding

TSP-4 genetic variants in atherogenesis and angiogenesisR01HL117216 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN, STENINA, OLGA I · 2013 to 2017
$1.9M
Tissue Specific Regulation of Diabetes-Associated Cancer GrowthR01CA177771 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI STENINA, OLGA I · 2014 to 2018
$1.6M
Regulation of thrombospondin-1 expression by glucoseR01DK067532 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI STENINA, OLGA I · 2006 to 2010
$1.4M
NCI NIH HHS R01 CA177771NCI NIH HHS R01CA177771NHLBI NIH HHS R01 HL117216NHLBI NIH HHS R01HL117216NIDDK NIH HHS DK067532NIDDK NIH HHS R01 DK067532
6 · The paper itself

Abstract

objectiveThrombospondin-4 (TSP-4) is 1 of the 5 members of the thrombospondin protein family. TSP-1 and TSP-2 are potent antiangiogenic proteins. However, angiogenic properties of the 3 other TSPs, which do not contain the domains associated with the antiangiogeneic activity of TSP-1 and TSP-2, have not been explored. In our previous studies, we found that TSP-4 is expressed in the vascular matrix of blood vessels of various sizes and is especially abundant in capillaries. We sought to identify the function of TSP-4 in the regulation of angiogenesis. APPROACH AND

resultsThe effect of TSP-4 in in vivo angiogenesis models and its effect on angiogenesis-related properties in cultured cells were assessed using Thbs4(-/-) mice, endothelial cells (EC) derived from these mice, and recombinant TSP-4. Angiogenesis was decreased in Thbs4(-/-) mice compared with wild-type mice. TSP-4 was detected in the lumen of the growing blood vessels. Mice expressing the P387 TSP-4 variant, which was previously associated with coronary artery disease and found to be more active in its cellular interactions, displayed greater angiogenesis compared with A387 form. Lung EC from Thbs4(-/-) mice exhibited decreased adhesion, migration, and proliferation capacities compared with EC from wild-type mice. Recombinant TSP-4 promoted proliferation and the migration of EC. Integrin α2 and gabapentin receptor α2δ-1 were identified as receptors involved in regulation of EC adhesion, migration, and proliferation by TSP-4.

conclusionTSP-4, an extracellular matrix protein previously associated with tissue remodeling, is now demonstrated to possess proangiogenic activity.

Indexed as

ApoptosisAnimalsCell AdhesionCells, CulturedDisease Models, AnimalDNADNA Mutational AnalysisFemaleImmunohistochemistryMaleMiceMice, Inbred C57BLNeovascularization, PathologicThrombospondinsDNAthrombospondin 4Thrombospondinsangiogenesisextracellular matrixthrombospondin-4

Identifiers

PMID26139464
PMCPMC4629500
OpenAlexW2105614538

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.